查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414327

2024 年神经调节体内设备全球市场报告

Internal Neuromodulation Devices Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经调节体内设备的市场规模强劲成长。将从2023年的24.7亿美元成长到2024年的26.6亿美元，复合年增长率为7.7%。这种时间的延长是由于慢性疼痛管理、人口老化、对临床研究和临床试验的日益关注、神经系统疾病的流行以及患者对关键字认识和接受度的提高等因素造成的。

神经调节体内设备市场规模预计在未来几年将强劲成长。 2028年，这一数字将以7.9%的复合年增长率成长至36.1亿美元。预测期内的预期成长是由个人化医疗趋势、医疗保健支出增加、行业联盟和合作伙伴关係、对患者结果和现实世界证据的关注以及监管环境的变化所推动的。预测期内预计的主要趋势包括小型化和植入技术的进步、无线连接和远端监控的整合、神经调节的扩展应用、用于精确调节的封闭回路型系统的开发以及以患者为中心的设计。

由于神经系统疾病盛行率的预期增加，神经调节体内设备市场预计在可预见的未来将成长。神经系统疾病包括影响神经系统的多种疾病，包括大脑、脊髓和周边神经。神经调节内部装置透过向神经系统的特定区域提供电刺激来缓解慢性疼痛、运动障碍和情绪障碍等症状，在神经和精神疾病的治疗中发挥重要作用。这些设备透过减轻症状和使日常生活变得更加轻鬆，有助于改善患者的生活品质。例如，2021年，美国疾病管制与预防中心宣布，阿兹海默症影响约620万65岁以上的美国，到2060年，这一数字将增加近三倍，达到1,400万。预计此外，65 岁以后，发病率每五年翻一番。因此，神经系统疾病的日益普及正在推动神经调节体内设备市场的成长。

预计脑肿瘤盛行率的上升将推动神经调节体内设备市场的扩张。脑肿瘤是发生在大脑和脊髓中的一组不同的肿瘤，对理解和治疗提出了复杂的挑战。神经调节体内设备已成为治疗多种脑部疾病的一种有前途的治疗解决方案，可将电刺激或其他型态的能量直接传递到大脑的特定区域，以调节神经细胞活动并提高治疗效果。根据美国脑肿瘤协会报告，到 2022 年，大约有 94,390 名美国将被诊断出患有脑肿瘤，到 2023 年，估计将有 18,990 人死于恶性脑肿瘤。因此，脑肿瘤发生率的增加是神经调节体内设备市场成长的催化剂。

2023年，北美是神经调节体内设备市场最大的地区。在全球神经调节体内设备市场报告中，亚太地区预计将成为预测期内成长最快的地区。神经调节体内设备市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球神经调节体内设备市场，按类型、表现和预测细分，2018-2023、2023-2028、2033
  • 脊髓刺激设备
  • 深部脑部刺激器
  • 荐骨神经刺激器
  • 迷走神经刺激设备
  • 胃神经刺激设备
  • 全球神经调节体内设备市场，依技术类型、表现及预测细分，2018-2023、2023-2028、2033
  • 内部神经调节
  • 体外神经调节
  • 全球神经调节体内设备市场，依生物材料细分、性能与预测，2018-2023、2023-2028、2033
  • 金属生物材料
  • 高分子生物材料
  • 陶瓷生物材料
  • 全球神经调节体内设备市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 腰部手术失败综合症
  • 帕金森氏症
  • 尿失禁
  • 癫痫
  • 胃轻瘫
  • 全球神经调节体内设备市场，依最终用户细分、性能和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 家庭保健
  • 社区健康保健

第 7 章 区域与国家分析

  • 全球神经调节体内设备市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球神经调节体内设备市场，按国家、表现和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 神经调节体内设备市场竞争形势
  • 神经调节体内设备市场公司概况
    • Medtronic plc
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • BioControl Medical Ltd.
    • Aleva Neurotherapeutics SA

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r11837

“Internal Neuromodulation Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on internal neuromodulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for internal neuromodulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The internal neuromodulation devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
  • 2) By Technology Type: Internal Neuromodulation; External Neuromodulation
  • 3) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
  • 4) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
  • 5) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Cyberonics Inc.; BioControl Medical Ltd.; Aleva Neurotherapeutics SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.

The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.

The internal neuromodulation devices market research report is one of a series of new reports from The Business Research Company that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The expansion observed in the historical period can be attributed to factors such as the management of chronic pain, the aging population, increased focus on clinical research and trials, the prevalence of neurological disorders, and growing patient awareness and acceptance of internal neuromodulation devices.

The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to trends in personalized medicine, increasing healthcare expenditure, collaborations and partnerships within the industry, a focus on patient outcomes and real-world evidence, and changes in the regulatory landscape. Key trends expected in the forecast period encompass advancements in miniaturization and implantable technology, the integration of wireless connectivity and remote monitoring, expanded applications for neuromodulation, the development of closed-loop systems for precise modulation, and a heightened focus on patient-centric design.

The anticipated increase in the prevalence of neurologic diseases is poised to drive the growth of the internal neuromodulation devices market in the foreseeable future. Neurologic diseases encompass a wide range of disorders affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices play a crucial role in treating neurological and psychiatric conditions by administering electrical stimulation to specific areas of the nervous system, offering relief from symptoms such as chronic pain, movement disorders, and mood disorders. These devices contribute to enhancing patients' quality of life by alleviating symptoms and facilitating daily activities. For example, in 2021, the Centers for Disease Control and Prevention reported that Alzheimer's disease affected approximately 6.2 million Americans aged 65 and older, a number expected to nearly triple to 14 million by 2060. Additionally, the incidence of the disease doubles every five years after the age of 65. Thus, the increasing prevalence of neurologic diseases is a driving force behind the growth of the internal neuromodulation devices market.

The rising incidence of brain cancers is anticipated to fuel the expansion of the internal neuromodulation devices market. Brain cancer, a diverse group of tumors originating in the brain or spinal cord, poses complex challenges for understanding and treatment. Internal neuromodulation devices emerge as a promising therapeutic solution for various brain disorders, delivering electrical stimulation or other forms of energy directly to specific brain regions to modulate neuronal activity and induce therapeutic effects. In 2022, the National Brain Tumor Society reported an expected diagnosis of brain tumors in approximately 94,390 Americans, with an estimated 18,990 deaths from malignant brain tumors in 2023. Thus, the growing incidence of brain cancers serves as a catalyst for the growth of the internal neuromodulation devices market.

A prominent trend gaining traction in the internal neuromodulation devices market is product innovation. Major companies in this segment are actively engaged in developing new technologies to maintain their market positions. For instance, in March 2023, Ireland-based medical equipment manufacturer Neuromod Device Ltd. announced that its Lenire system had received De Novo clearance from the US Food and Drug Administration (FDA). The Lenire system employs a combination of sound stimulation and tongue stimulation to treat tinnitus, a neurological disorder characterized by ringing in the ears. This innovative system uses a dual-pronged approach to neurostimulation, utilizing Bluetooth headphones to play unique sounds stimulating the auditory nerve, while Neuromod's Tonguetip device transmits moderate electrical stimulation to the tongue's surface. This technology provides otolaryngologists with an innovative tool to recommend to patients experiencing a moderately negative impact on their lives due to tinnitus.

Major companies in the internal neuromodulation devices market are concentrating on developing technological innovations, including digital health apps, to gain a competitive edge. Digital health apps are software applications designed to deliver health-related services and information to users on mobile devices. For example, in July 2022, US-based medical device provider Abbott Laboratories launched the NeuroSphere Virtual Clinic, a groundbreaking technology allowing patients with Abbott's neurostimulation devices to remotely communicate with doctors. This feature enables patients to ensure proper settings, functionality, and receive new treatment settings via secure in-app video chat and integrated remote programming. The platform provides real-time data to physicians about patients' device usage and pain levels.

In March 2022, US-based medical equipment manufacturer Electromedical Products International (EPI) acquired Pulvinar Neuro for an undisclosed amount. Through this acquisition, Pulvinar Neuro gains enhanced capabilities for promoting its patented technologies, such as transcranial alternating current stimulation (tACS). Additionally, the acquisition enhances its cloud-enabled digital treatments for mental and neurological conditions and customized feedback stimulation. Pulvinar Neuro is a US-based medical technology company specializing in deep brain stimulation (DBS) systems for treating neurological and psychiatric disorders.

Major companies operating in the internal neuromodulation devices market report are Medtronic plc, Boston Scientific Corporation, Cyberonics Inc., BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, St. Jude Medical Inc., EnteroMedics Inc., Micron Medical Corporation, LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Accellent Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

North America was the largest region in the internal neuromodulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Internal Neuromodulation Devices Market Characteristics

3. Internal Neuromodulation Devices Market Trends And Strategies

4. Internal Neuromodulation Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Internal Neuromodulation Devices Market Size and Growth

  • 5.1. Global Internal Neuromodulation Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Internal Neuromodulation Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Internal Neuromodulation Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Internal Neuromodulation Devices Market Segmentation

  • 6.1. Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Neuro Stimulator
  • 6.2. Global Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation
  • 6.3. Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • 6.4. Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Failed Back Surgery Syndrome
  • Parkinson's Disease
  • Urinary Incontinence
  • Epilepsy
  • Gastroparesis
  • 6.5. Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare
  • Community Healthcare

7. Internal Neuromodulation Devices Market Regional And Country Analysis

  • 7.1. Global Internal Neuromodulation Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Internal Neuromodulation Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Internal Neuromodulation Devices Market

  • 8.1. Asia-Pacific Internal Neuromodulation Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Internal Neuromodulation Devices Market

  • 9.1. China Internal Neuromodulation Devices Market Overview
  • 9.2. China Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Internal Neuromodulation Devices Market

  • 10.1. India Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Internal Neuromodulation Devices Market

  • 11.1. Japan Internal Neuromodulation Devices Market Overview
  • 11.2. Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Internal Neuromodulation Devices Market

  • 12.1. Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Internal Neuromodulation Devices Market

  • 13.1. Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Internal Neuromodulation Devices Market

  • 14.1. South Korea Internal Neuromodulation Devices Market Overview
  • 14.2. South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Internal Neuromodulation Devices Market

  • 15.1. Western Europe Internal Neuromodulation Devices Market Overview
  • 15.2. Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Internal Neuromodulation Devices Market

  • 16.1. UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Internal Neuromodulation Devices Market

  • 17.1. Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Internal Neuromodulation Devices Market

  • 18.1. France Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Internal Neuromodulation Devices Market

  • 19.1. Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Internal Neuromodulation Devices Market

  • 20.1. Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Internal Neuromodulation Devices Market

  • 21.1. Eastern Europe Internal Neuromodulation Devices Market Overview
  • 21.2. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Internal Neuromodulation Devices Market

  • 22.1. Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Internal Neuromodulation Devices Market

  • 23.1. North America Internal Neuromodulation Devices Market Overview
  • 23.2. North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Internal Neuromodulation Devices Market

  • 24.1. USA Internal Neuromodulation Devices Market Overview
  • 24.2. USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Internal Neuromodulation Devices Market

  • 25.1. Canada Internal Neuromodulation Devices Market Overview
  • 25.2. Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Internal Neuromodulation Devices Market

  • 26.1. South America Internal Neuromodulation Devices Market Overview
  • 26.2. South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Internal Neuromodulation Devices Market

  • 27.1. Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Internal Neuromodulation Devices Market

  • 28.1. Middle East Internal Neuromodulation Devices Market Overview
  • 28.2. Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Internal Neuromodulation Devices Market

  • 29.1. Africa Internal Neuromodulation Devices Market Overview
  • 29.2. Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Internal Neuromodulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Internal Neuromodulation Devices Market Competitive Landscape
  • 30.2. Internal Neuromodulation Devices Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Boston Scientific Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cyberonics Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. BioControl Medical Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Aleva Neurotherapeutics SA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Internal Neuromodulation Devices Market Competitive Benchmarking

32. Global Internal Neuromodulation Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Internal Neuromodulation Devices Market

34. Internal Neuromodulation Devices Market Future Outlook and Potential Analysis

  • 34.1 Internal Neuromodulation Devices Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Internal Neuromodulation Devices Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Internal Neuromodulation Devices Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer